SAT Hospital in Keralam rejects charges of ‘clinical trial drugs’ given to SMA-afflicted children

Hospital Superintendent says decision to provide SMA patients with a less expensive, generic version of the original molecule against SMA, in place of the imported original drug costing several lakhs of rupees for a single vial, was taken by a technical committee comprising experts in the field
Read the full report on The Hindu
Story file
How this page works. The Headline Update lists this report from The Hindu with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

